Reports on positron emission tomography have become more common in the oncology
literature. After a short introduction to positron emission tomography, this review will look at …

The potential use of positron emission tomography (PET) imaging in patients with non–small
cell lung cancer (NSCLC) is broadly divided into 5 categories: management of solitary …

Positron emission tomography (PET) has been in existence and continuously developing
over the past 20 years. In the last few years steady advances in the technology used for PET …

Carcinoma of the lung is one of the most frequent malignancies and a major cause of
mortality. The use of positron emission tomography (PET) has been extensively investigated …

BACKGROUND.: A need exists for an accurate, noninvasive means of staging non—small
cell lung cancer. METHODS.: A prospective evaluation of regional and whole-body positron …

Positron emission tomography (PET) represents a dramatic advance in the imaging of lung
cancer. It is valuable for the diagnosis, staging, prognosis, and restaging of disease, and is …

Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …

Study objective: Positron emission tomography (PET) cancontribute to diagnosing and
staging lung cancer, but it has not beendetermined whether this information influences …

The availability of clinical positron emission tomography (PET) is increasing rapidly in the
developed world (1). This article reviews the role of PET scanning in lung cancer …

Background. Positron emission tomography imaging is gaining popularity as a noninvasive
staging tool in non-small cell lung cancer. Nonmalignant processes can also affect radio …